Bronchiectasis: The era of precision medicine

Discover the latest insights on Bronchiectasis in the next RESP seminar in the series.

Recorded: Monday 5 October 2026

About the session

This insightful and educational session is part of the RESP (Respiratory Expert Speaker and Patient) webinar series, proudly presented by Respiratory Futures, INSPIRE and Asthma + Lung UK.

What was covered:

• Management of bronchiectasis
• Novel treatment options
• Expert patient insights

Meet the speaker

Professor James Chalmers took up the Rhodes Professorship of Experimental Therapeutics and Clinical Pharmacology at the University of Oxford in November 2025. Previously, he served as the Asthma + Lung UK Chair of Respiratory Research at the University of Dundee and as a Consultant Respiratory Physician.

James leads a translational research group focused on developing new treatments for bronchiectasis and is also interested in COPD, pneumonia, and associated conditions. He has published over 500 peer-reviewed papers, including landmark trials that have changed practice in bronchiectasis.

He has chaired five international guidelines panels, including the recent ERS bronchiectasis guidelines. He is the Chief Editor of the European Respiratory Journal.